Rationale [idcn]
Using [ftcn]
Raloxifene [orch, phsu]
PREVENT [phsu]
Osteoporosis [dsyn]
Breast [bpoc]
Cancer [neop]
postmenopausal [tmco]
Women [popg]
Osteoporosis [dsyn]
Fracture [inpo]
Breast Cancer [neop]
Health [idcn]
Issue [fndg]
postmenopausal [tmco]
Women [popg]
Well [qlco]
Known [qlco]
Estrogen [horm, phsu, strd]
Estrogen Receptors [aapp, rcpt]
Play [dora]
Role [socb]
pathogenesis [ftcn]
Diseases [dsyn]
Past [tmco]
Decade [qnco]
Hormone Therapy [topp]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Frequently [tmco]
Purpose [ftcn]
PREVENT [phsu]
treating [topp]
Osteoporosis, Post-Menopausal [dsyn]
Efficacy [qlco]
Contribute [acty]
Increase [ftcn]
Breast Cancer [neop]
Currently [tmco]
Estrogen [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Increasing [ftcn]
Understanding [menp]
Action [ftcn]
Estrogen [horm, phsu, strd]
LED [mnob]
Design [acty]
New [tmco]
Drugs [phsu]
Work [ocac]
Interaction [ftcn]
Drugs [phsu]
To [qlco]
Known [qlco]
Selective Estrogen Receptor Modulators [horm, phsu]
Not [ftcn]
Only [qnco]
effective [qlco]
PREVENT [phsu]
Osteoporosis [dsyn]
Managing [ocac]
Osteoporosis [dsyn]
Decreasing [qlco]
Incidence [qnco]
Breast Cancer [neop]
Selective Estrogen Receptor Modulators [horm, phsu]
Raloxifene [orch, phsu]
Most [qnco]
Attractive [qlco]
Agent [chvf]
Based [ftcn]
Evidence [ftcn]
Five [qnco]
Recent [tmco]
Large [qnco]
Trial [resa]
Multiple [qnco]
Outcome [ftcn]
Raloxifene [orch, phsu]
Evaluation [ftcn]
Continuing [idcn]
Outcome [ftcn]
Relevant [qlco]
Evista [orch, phsu]
Raloxifene [orch, phsu]
Heart [bpoc]
Study [mnob]
Tamoxifen [orch, phsu]
Raloxifene [orch, phsu]
Evista [orch, phsu]
Alendronate [opco, phsu]
Former [tmco]
Three [qnco]
Trial [resa]
Show [inpr]
Raloxifene [orch, phsu]
Not [ftcn]
Only [qnco]
Decrease [qlco]
Incidence [qnco]
osteoporosis fracture [dsyn]
Associated [qlco]
Efficacy [qlco]
breast cancer prevention [topp]
Head [blor]
Comparison [acty]
Fracture [inpo]
Agent [chvf]
Alendronate [opco, phsu]
Evista [orch, phsu]
Alendronate [opco, phsu]
Trial [resa]
Chemoprevention [topp]
Agent [chvf]
Tamoxifen [orch, phsu]
study trial [resa]
Tamoxifen [orch, phsu]
Raloxifene [orch, phsu]
Further [spco]
confirmed [qlco]
Raloxifene [orch, phsu]
Better [qlco]
choice [inbe]
conclude [bodm, orch]
absence [qnco]
Therapeutic Effect [hlca]
relieving [ftcn]
Climacteric [orgf]
symptoms [ftcn]
Presence [topp]
Potential [qlco]
Risk [qlco]
Thromboembolism [dsyn]
Raloxifene [orch, phsu]
Drug [phsu]
prescribed [hlca]
Clear [qlco]
Indications [idcn]
Management [ocac]
Osteoporosis [dsyn]
Prevention [topp]
Fracture [inpo]
Decreasing [qlco]
Incidence [qnco]
Invasive Breast Cancer [neop]
Care [acty]
Monitoring [hlca]
Thromboembolism [dsyn]
Raloxifene [orch, phsu]
Appropriate [qlco]
Medicine [phsu]
Target [ftcn]
Climacteric [orgf]
Symptom [sosy]
free [ftcn]
postmenopausal [tmco]
Women [popg]
Overall [inpr]
Favorable [qlco]
risk benefit [qlco]
Safety [hcpp]
Profile [lbpr]
Using [ftcn]
Global [spco]
Index [inpr]
PROPOSED [idcn]
Initiation [menp]
WHI [inpr]
[c] [qnco]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
